ABVC BioPharma, Inc.
Income Statement
| Line Item | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|
| Revenue | $50.0M | $0 | $7.8K | $5.7K | $3.2K | $14.9K |
| Cost of Revenue | $521 | $0 | — | — | — | — |
| Gross Profit | $2.8K | $0 | — | — | — | — |
| Gross Margin | 0.0% | — | — | — | — | — |
| Operating Expenses | ||||||
| Research & Development | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | $1.9M | $1.9M |
| Operating Income | — | — | $-177.3K | $-1.1M | $-1.9M | $-1.9M |
| Operating Margin | — | — | -2,276.3% | -20,004.3% | -59,180.7% | -12,715.2% |
| Interest Expense | $0 | $0 | $49.1K | $87.7K | $204.9K | $-218.6K |
| Pretax Income | — | — | — | — | — | — |
| Income Tax Expense | — | — | $0 | $67.6K | $0 | — |
| Net Income | $-32.3K | $-23.2K | $-226.4K | $-1.1M | $-1.2M | $-1.9M |
| Net Margin | -0.1% | — | -2,906.8% | -18,718.6% | -38,202.2% | -12,793.1% |
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 585.1M | 585.4M | 2.87T | 743.79B | 511.58B | 345.78B |
| Shares Outstanding (Diluted) | 585.1M | 585.4M | 2.87T | 743.79B | 511.58B | 345.78B |
| Dividends Per Share | — | — | — | — | — | — |